Health Care & Life Sciences » Biotechnology | Zealand Pharma A/S

Zealand Pharma A/S

Zealand Pharma A/S
Stock Exchange Copenhagen Stock Exchange
EPS
DKK17.75
Market Cap
DKK4.68 B
Shares Outstanding
31.81 M
Public Float
24.48 M

Profile

Address
Smedeland 36
Glostrup ZE 2600
Denmark
Employees -
Website http://www.zealandpharma.com
Updated 07/08/2019
Zealand Pharma A/S is a biotechnology company that engages in the discovery, design, and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark.

Financials

View All

Kirsten Dreyer
Director
Jens Peter Stenvang
Director